These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19276245)

  • 1. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.
    Kanazawa T; Kommareddi PK; Iwashita T; Kumar B; Misawa K; Misawa Y; Jang I; Nair TS; Iino Y; Carey TE
    Clin Cancer Res; 2009 Apr; 15(7):2222-30. PubMed ID: 19276245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.
    Kanazawa T; Misawa K; Misawa Y; Maruta M; Uehara T; Kawada K; Nagatomo T; Ichimura K
    Mol Med Rep; 2014 Sep; 10(3):1289-94. PubMed ID: 25017118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
    Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.
    Kanazawa T; Iwashita T; Kommareddi P; Nair T; Misawa K; Misawa Y; Ueda Y; Tono T; Carey TE
    Oncogene; 2007 Aug; 26(39):5762-71. PubMed ID: 17384686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.
    Kanazawa T; Misawa K; Carey TE
    Expert Opin Ther Targets; 2010 Mar; 14(3):289-302. PubMed ID: 20148716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.
    Banerjee R; Henson BS; Russo N; Tsodikov A; D'Silva NJ
    Cell Signal; 2011 Jul; 23(7):1110-8. PubMed ID: 21345369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells.
    Berger A; Lang R; Moritz K; Santic R; Hermann A; Sperl W; Kofler B
    Endocrinology; 2004 Feb; 145(2):500-7. PubMed ID: 14592962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).
    Tofighi R; Joseph B; Xia S; Xu ZQ; Hamberger B; Hökfelt T; Ceccatelli S
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2717-22. PubMed ID: 18272487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
    Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21
    Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP
    Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
    Kanazawa T; Misawa K; Misawa Y; Uehara T; Fukushima H; Kusaka G; Maruta M; Carey TE
    Toxins (Basel); 2015 Aug; 7(8):2959-84. PubMed ID: 26251921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma.
    de Medeiros MC; Liu M; Banerjee R; Bellile E; D'Silva NJ; Rossa C
    Cell Oncol (Dordr); 2022 Apr; 45(2):241-256. PubMed ID: 35267186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
    Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
    Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of galanin receptor 1 in head and neck cancer.
    Misawa K; Ueda Y; Kanazawa T; Misawa Y; Jang I; Brenner JC; Ogawa T; Takebayashi S; Grenman RA; Herman JG; Mineta H; Carey TE
    Clin Cancer Res; 2008 Dec; 14(23):7604-13. PubMed ID: 19047085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.